The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.

Hendrik Van Den Berg

The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.

Hendrik Van Den Berg

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1771-1775
Number of pages	5
Journal	European Journal of Cancer
Volume	29A(12)
Publication status	Published - 1993

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{1d79f1be69ea487db2fb94584a259929,

title = "The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.",

author = "{Van Den Berg}, Hendrik",

year = "1993",

language = "English",

volume = "29A(12)",

pages = "1771--1775",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

}

The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor. / Van Den Berg, Hendrik.

In: European Journal of Cancer, Vol. 29A(12), 1993, p. 1771-1775.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.

AU - Van Den Berg, Hendrik

PY - 1993

Y1 - 1993

M3 - Article

C2 - 8398308

VL - 29A(12)

SP - 1771

EP - 1775

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -